These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 38385501

  • 21. Effect of electrical stimulation as an adjunct to botulinum toxin type A in the treatment of adult spasticity: a systematic review.
    Intiso D, Santamato A, Di Rienzo F.
    Disabil Rehabil; 2017 Oct; 39(21):2123-2133. PubMed ID: 27764971
    [Abstract] [Full Text] [Related]

  • 22. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia?
    Tereshko Y, Valente M, Belgrado E, Dalla Torre C, Dal Bello S, Merlino G, Gigli GL, Lettieri C.
    Toxins (Basel); 2023 Nov 14; 15(11):. PubMed ID: 37999517
    [Abstract] [Full Text] [Related]

  • 23. Botulinum toxin type B for cervical dystonia.
    Marques RE, Duarte GS, Rodrigues FB, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J.
    Cochrane Database Syst Rev; 2016 May 13; 2016(5):CD004315. PubMed ID: 27176573
    [Abstract] [Full Text] [Related]

  • 24. Botulinum toxin type A therapy for cervical dystonia.
    Rodrigues FB, Duarte GS, Marques RE, Castelão M, Ferreira J, Sampaio C, Moore AP, Costa J.
    Cochrane Database Syst Rev; 2020 Nov 12; 11(11):CD003633. PubMed ID: 33180963
    [Abstract] [Full Text] [Related]

  • 25. Botulinum toxin for the treatment of strabismus.
    Rowe FJ, Noonan CP.
    Cochrane Database Syst Rev; 2017 Mar 02; 3(3):CD006499. PubMed ID: 28253424
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia.
    Liu J, Xu YY, Zhang QL, Luo WF.
    Pain Res Manag; 2018 Mar 02; 2018():7365148. PubMed ID: 29849847
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.
    Lakhan SE, Velasco DN, Tepper D.
    Pain Med; 2015 Sep 02; 16(9):1773-80. PubMed ID: 25800040
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study.
    Zhang H, Lian Y, Xie N, Chen C, Zheng Y.
    J Headache Pain; 2017 Aug 10; 18(1):81. PubMed ID: 28799056
    [Abstract] [Full Text] [Related]

  • 33. Botulinum toxin in trigeminal neuralgia.
    Castillo-Álvarez F, Hernando de la Bárcena I, Marzo-Sola ME.
    Med Clin (Barc); 2017 Jan 06; 148(1):28-32. PubMed ID: 27743594
    [Abstract] [Full Text] [Related]

  • 34. Botulinum toxin in the treatment of trigeminal neuralgia: 6-Month follow-up.
    Türk Börü Ü, Duman A, Bölük C, Coşkun Duman S, Taşdemir M.
    Medicine (Baltimore); 2017 Sep 06; 96(39):e8133. PubMed ID: 28953646
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.